Provided by Tiger Trade Technology Pte. Ltd.

Agenus

9.93
+0.04000.40%
Pre-market: 9.980.0500+0.50%08:39 EDT
Volume:1.37M
Turnover:13.58M
Market Cap:447.05M
PE:3.97
High:10.31
Open:9.92
Low:9.62
Close:9.89
52wk High:10.31
52wk Low:2.71
Shares:45.02M
Float Shares:40.38M
Volume Ratio:1.11
T/O Rate:3.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-2.25
PE(LYR):-2,924.03

Loading ...

Agenus Shares Rise After Chardan Initiates Coverage at Buy

MT Newswires Live
·
Sep 29

Agenus Initiated at Buy by Rodman & Renshaw

Dow Jones
·
Sep 28

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 22

Chardan Initiates Agenus at Buy With $40 Price Target

MT Newswires Live
·
Sep 18

Agenus initiated with a Buy at Chardan

TIPRANKS
·
Sep 18

Agenus Director Marco Tullio Marcucci Files Initial Beneficial Ownership Statement

Reuters
·
Sep 16

Agenus files to sell 221,525 shares of common stock for holders

TIPRANKS
·
Sep 12

Agenus to Present 3-Year Survival Data for Botensilimab-Balstilimab Ovarian Cancer Study at IGCS 2026

Reuters
·
Sep 10

Agenus Releases Corporate Overview Presentation on Botensilimab-Balstilimab Neoadjuvant Colon Cancer Data

Reuters
·
Sep 03

Agenus Joins Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 31

Agenus Reports 21.2-Month Median Survival in Phase 1b Bot+bal Study for MSS Metastatic Colorectal Cancer

Reuters
·
Aug 28

Agenus: No colorectal cancer recurrences observed at updated follow-up in trial

TIPRANKS
·
Aug 26

Agenus Reports no Recurrences in Phase 2 NEST Trial of Botensilimab Plus Balstilimab in Resectable Colon Cancer

Reuters
·
Aug 26

Agenus Posts Investor Deck Spotlighting Botensilimab-Balstilimab Neoadjuvant Program in MSS Colon Cancer

Reuters
·
Aug 21

Agenus Modifies Loan and Issues Unregistered Equity

TIPRANKS
·
Aug 19

Agenus - Unit Enters Second Loan Modification Agreement with Ocean 1181 on Aug 12, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus - Loan Principal $24.75 Mln, Maturity Extended to Nov 30, 2029, Interest 13.0% Per Annum - SEC Filing

THOMSON REUTERS
·
Aug 19

Agenus Extends $24.75 Million Loan Maturity to Nov. 2029 in Ocean 1181 Amendment

Reuters
·
Aug 19

Agenus Grants CEO Garo Armen 1,971,500 Performance-Based Stock Options at $7.78 Per Share

Reuters
·
Aug 13

Agenus Strengthens Board With New Director Appointment

TIPRANKS
·
Aug 12